CX157 explained

CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA).^[1] As of 2007 it was in phase II clinical trials for the treatment of depression.^[2] In 2013, work on the drug was terminated.http://adisinsight.springer.com/drugs/800025697

Notes and References

1. Fielding R, Mielach F, Free J, Pande A . Pharmacokinetics and oral bioavailability of CX157, a reversible selective MAO-A inhibitor, in primates . 2007 . 2007 AAPS Annual Meeting & Exposition . 2009-06-14 . https://web.archive.org/web/20110526192425/http://www.aapsj.org/abstracts/AM_2007/AAPS2007-001233.PDF . 2011-05-26 . dead .
2. }